The role of mast cell tryptases in cardiac myxoma: Histogenesis and development of a challenging tumor

Oncology Letters

Volumn 8, Issue 1, 2014, Pages 379-383

  Donato, Giuseppe ^a   Conforti, Francesco ^a   Camastra, Caterina ^a   Ammendola, Michele ^a   Donato, Annalidia ^a   Renzulli, Attilio ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Angiogenesis; Cardiac myxoma; Mast cells; Tryptase

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; STEM CELL FACTOR RECEPTOR; TRYPTASE;

ADULT; ANGIOGENESIS; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; FEMALE; HEART MYXOMA; HISTOGENESIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY; MIDDLE AGED;

EID: 84901231144     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2104     Document Type: Article

References (30)

1. Riberi A, Gariboldi V, Grisoli D, et al: Cardiac tumors. Rev Pneumol Clin 66: 95-103, 2010.
2. Carney JA, Gordon H, Carpenter PC, et al: The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore) 64: 270-283, 1985.
3. Rhodes AR, Silverman RA, Harrist TJ, et al: Mucocutaneous lentigines, cardiomucocutaneous myxomas, and multiple blue nevi: the 'LAMB' syndrome. J Am Acad Dermatol 10: 72-82, 1984.
4. Burke AP, Tazeelar H, Gomez-Roman JJ, et al: Benign tumours of pluripotent mesenchyme. In: World Health Organization: Tumours of the Lung, Pleura, Thymus and Heart. Travis WD, Brambilla E, Muller-Hermelink HK and Harris CC (eds). IARC Press, Lyon, pp260-265, 2004.
5. Ribatti D and Crivellato E: The controversial role of mast cells in tumor growth. Int Rev Cell Mol Biol 275: 89-131, 2009.
6. Ribatti D, Crivellato E, Roccaro AM, et al: Mast cell contribution to angiogenesis related to tumour progression. Clin Exp Allergy 34: 1660-1664, 2004.
7. Benitez-Bribiesca L, Wong A, Utrera D, et al: The role of mast cell tryptase in neoangiogenesis of premalignant and malignant lesions of the uterine cervix. J Histochem Cytochem 49: 1061-1062, 2001.
8. McNeil HP, Adachi R and Stevens RL: Mast cell-restricted tryptases: structure and function in inflammation and pathogen defense. J Biol Chem 282: 20785-20789, 2007.
9. Ammendola M, Zuccala V, Patruno R, et al: Tryptase-positive mast cells and angiogenesis in keloids: a new possible post-surgical target for prevention. Updates Surg 65: 53-57, 2013.
10. Weidner N, Semple JP, Welch WR, et al: Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991.
11. Acebo E, Val-Bernal JF and Gomez-Roman JJ: Thrombomodulin, calretinin and c-kit (CD117) expression in cardiac myxoma. Histol Histopathol 16: 1031-1036, 2001.
12. Arock M, Schneider E, Boissan M, et al: Differentiation of human basophils: an overview of recent advances and pending questions. J Leukoc Biol 71: 557-564, 2002.
13. Sperr WR, Bankl HC, Mundigler G, et al: The human cardiac mast cell: localization, isolation, phenotype, and functional characterization. Blood 84: 3876-3884, 1994.
14. Donato G, Conforti F, Zuccala V, et al: Expression of tenascin-c and CD44 receptors in cardiac myxomas. Cardiovasc Pathol 18: 173-177, 2009.
15. Orlandi A, Ciucci A, Ferlosio A, et al: Cardiac myxoma cells exhibit embryonic endocardial stem cell features. J Pathol 209: 231-239, 2006.
16. Zhou Y, Pan P, Yao L, et al: CD117-positive cells of the heart: progenitor cells or mast cells? J Histochem Cytochem 58: 309-316, 2010.
17. Harris IS and Black BL: Development of the endocardium. Pediatr Cardiol 31: 391-399, 2010.
18. Milgrom-Hoffman M, Harrelson Z, Ferrara N, et al: The heart endocardium is derived from vascular endothelial progenitors. Development 138: 4777-4787, 2011.
19. Andrews RG, Singer JW and Bernstein ID: Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood 67: 842-845, 1986.
20. Krause DS, Fackler MJ, Civin CI, et al: CD34: structure, biology, and clinical utility. Blood 87: 1-13, 1996.
21. Nielsen JS and McNagny KM: CD34 is a key regulator of hematopoietic stem cell trafficking to bone marrow and mast cell progenitor trafficking in the periphery. Microcirculation 16: 487-496, 2009.
22. van Beijnum JR, van der Linden E and Griffioen AW: Angiogenic profiling and comparison of immortalized endothelial cells for functional genomics. Exp Cell Res 314: 264-272, 2008.
23. Siemerink MJ, Klaassen I, Vogels IM, et al: CD34 marks angiogenic tip cells in human vascular endothelial cell cultures. Angiogenesis 15: 151-163, 2012.
24. Theoharides TC and Conti P: Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol 25: 235-241, 2004.
25. Dyduch G, Kaczmarczyk K and Okon K: Mast cells and cancer: enemies or allies? Pol J Pathol 63: 1-7, 2012.
26. Ribatti D, Finato N, Crivellato E, et al: Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancer. Am J Obstet Gynecol 193: 1961-1965, 2005.
27. Takanami I, Takeuchi K and Naruke M: Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma. Cancer 88: 2686-2692, 2000.
28. Ammendola M, Sacco R, Donato G, et al: Mast cell positivity to tryptase correlates with metastatic lymph nodes in gastrointestinal cancer patients treated surgically. Oncology 85: 111-116, 2013.
29. Ribatti D, Guidolin D, Marzullo A, et al: Mast cells and angiogenesis in gastric carcinoma. Int J Exp Pathol 91: 350-356, 2010.
30. Groot Kormelink T, Abudukelimu A and Redegeld FA: Mast cells as target in cancer therapy. Curr Pharm Des 5: 1868-1878, 2009.